MannKind (MNKD) Stock Craters After Sanofi Ends Licensing Deal

MannKind Corp. (MNKD) shares nosedived more than 36% to $0.92 in early trade Tuesday, a record intraday low, after the company’s license agreement with French drugmaker Sanofi (SNY) was terminated. The company’s trading volume jumped on the news with the issue currently trading more than 20 million shares, compared to the average daily volume of […] View the full post at: MannKind (MNKD) Stock Craters After Sanofi Ends Licensing Deal Related posts: French Pharmaceutical Sanofi to Buy Merial Stake from Merck Merck and Sanofi Combine Animal Health Units Google Ends Search Advertising Deal with Yahoo